跳至主要内容
临床试验/NCT00524797
NCT00524797Unknown不适用

Profonycia - Honey for Improving Quality of Patient's Life Receiving Chemotherapy

Ziv Hospital2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2007年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
2

研究概览

简要总结

Myelosuppression (bone marrow suppression) is the most important toxic side effect of the majority of chemotherapeutic agents and typically is the dose limiting factor. Death occurring after chemotherapy usually results either from infection related to drug induced leucopenia or from bleeding related to thrombocytopenia. Colony stimulating factors (CSFs) are widely used in the treatment of chemotherapy induced neutropenia. The same Erythropoetines are used in the treatment of chemotherapy induced anemia. Both treatments are expensive and have several side effects.

In our previous stud (1) we found a special kind of honey: Life-Mel Honey to reduce the incidence of chemotherapy induced pancytopenia and improving quality of life.

The aim of the recent planed study is to provide prophylactic and protective treatment against neutropenia reducing the need for secondary CSF administration in patients receiving chemotherapy along with a natural and non expensive honey: Profonycia.

This honey which is expressed in Kibutz Shamir in Upper Galliee seems promising and easy for administration: given 5 gr/day per os for 7 days from the administration of chemotherapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients 18 years old or elder receiving chemotherapy 1/2-3 weeks

排除标准

  • •Patients below 18 years old

研究组 & 干预措施

Main

Active Comparator

50 patients will receive Profonycia 5 gr/day PO for 7 days

干预措施: Profonycia (Dietary Supplement)

研究者

发起方
Ziv Hospital
申办方类型
Other Gov

研究点 (2)

Loading locations...

相似试验